Home » Topics » Regulatory » Patents

Patents
RSS

EGFR tyrosine kinase inhibitors described by Pfizer

Nov. 19, 1996

RPR claims taxoid antineoplastic compounds

Nov. 19, 1996

Growth stimulant reported by American Cyanamid

Nov. 19, 1996

Hirudin-based thrombin inhibitors reported by Canadian investigators

Nov. 19, 1996

Glaxo Wellcome claims 5alpha-reductase inhibitors for BPH

Nov. 19, 1996

Novo Nordisk claims immunosuppressive serine palmitoyl transferase inhibitors

Nov. 19, 1996

Lilly reports agents to treat menopause-related conditions

Nov. 15, 1996

PKC inhibitors from Lilly for various therapeutic indications

Nov. 15, 1996

Takeda describes potential antidiabetic agents

Nov. 15, 1996

New 5-HT3/5-HT4 antagonists from Synthelabo

Nov. 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
IMV-101 shows promise for B-cell malignancies
BioWorld Science
IMV-101 is a new CAR T-cell therapy targeting CD19 developed by Suzhou Immunofoco Biotechnology Co. Ltd. for the potential treatment of B-cell malignancies and...